Cargando…

79. Mucosal Interferon (IFN) Responses in Infants with Respiratory Syncytial Virus (RSV) Infection to Inform Live Attenuated Vaccine (LAV) Development

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of hospitalization for infants. Several vaccine strategies for RSV are being developed. Among those, live attenuated vaccine (LAV) represent an attractive alternative for young children as they mimic natural infection and induce protec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taveras, Jeanette, Garcia-Maurino, Cristina, Mertz, Sara, Peeples, Mark E, Ramilo, Octavio, Mejias, Asuncion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809030/ http://dx.doi.org/10.1093/ofid/ofz359.003

Ejemplares similares

131. The Protective Role of Mucosal Interferons in Infants with Respiratory Syncytial Virus (RSV) Infection
por: Taveras, Jeanette, et al.
Publicado: (2020)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)

Respiratory Syncytial Virus (RSV)–Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants
por: Koivisto, Karoliina, et al.
Publicado: (2021)

1186. Increased Respiratory Syncytial Virus (RSV) Viral Replication Leads to Increased Cytokine Production and Polarized Interferon Response in Infant Mucosal Epithelium
por: Glowinski, Rebecca M, et al.
Publicado: (2021)

2783. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Infants with Severe Respiratory Syncytial Virus (RSV) Infection
por: Bedoya, Santiago Acero, et al.
Publicado: (2019)

118. Nasopharyngeal (NP) Bacterial Detection in Infants With Respiratory Syncytial Virus (RSV) Infection: Impact on Clinical Outcomes
por: Diaz, Alejandro, et al.
Publicado: (2018)

1465. Age-Dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children with Respiratory Syncytial Virus Infection (RSV) Infection
por: Brenes-Chacon, Helena, et al.
Publicado: (2020)

The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines
por: King, Tiffany, et al.
Publicado: (2021)

Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection
por: Garcia-Mauriño, Cristina, et al.
Publicado: (2019)

Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus (Rsv) Monoclonal Antibody Significantly Modifies The Local And Systemic Cytokine Responses Induced By Rsv In The Mouse Model
por: Mejías, Asunción, et al.
Publicado: (2007)

2352. Increased on Childhood Recurrent Wheezing and Asthma After Respiratory Syncytial Viral (RSV) Infection in Full-Term Infants
por: Mejias, Asuncion, et al.
Publicado: (2018)

A Systems Analysis Approach to Define the Protective Host Immune Responses of Children with Mild Respiratory Syncytial Virus Infection
por: Heinonen, Santtu, et al.
Publicado: (2017)

79. Children with COVID-19 Demonstrate Distinct Serum Cytokines Profiles According to Clinical Presentations
por: Xu, Zhaohui, et al.
Publicado: (2021)

Respiratory Syncytial Virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice
por: Torres, Juan Pablo, et al.
Publicado: (2010)

Respiratory Syncytial Virus bronchiolitis: Impact of second-hand smoke exposure on immune profiles
por: Diaz, Alejandro, et al.
Publicado: (2017)

Age and respiratory syncytial virus etiology in bronchiolitis clinical outcomes
por: Rodriguez-Fernandez, Rosa, et al.
Publicado: (2022)

Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: An experimental murine model
por: Chávez-Bueno, Susana, et al.
Publicado: (2005)

204. Mucosal Cytokine Profiles in Children with COVID-19
por: Cohen, Shira H, et al.
Publicado: (2021)

The importance of viral testing in infants and young children with bronchiolitis()
por: Mejias, Asuncion, et al.
Publicado: (2022)

Corrigendum to: 204. Mucosal Cytokine Profiles in Children with COVID-19
por: Quintero, Ana M, et al.
Publicado: (2022)

Superiority of Transcriptional Profiling Over Procalcitonin for Distinguishing Bacterial From Viral Lower Respiratory Tract Infections in Hospitalized Adults
por: Suarez, Nicolas M., et al.
Publicado: (2015)

Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
por: Hijano, Diego R., et al.
Publicado: (2019)

118 Transcriptional Profiling Discriminates Complete and Incomplete Kawasaki Disease (KD) from Adenovirus infection (HAdV)
por: Jaggi, Preeti, et al.
Publicado: (2014)

Viral Loads and Disease Severity in Children with Rhinovirus-Associated Illnesses
por: Sanchez-Codez, Maria I., et al.
Publicado: (2021)

LAV 1 Installation
por: Antonelli, A
Publicado: (2008)

LAV Fabrication and Installation
por: Moulson, M, et al.
Publicado: (2011)

Whole Blood Gene Expression Profiles to Assess Pathogenesis and Disease Severity in Infants with Respiratory Syncytial Virus Infection
por: Mejias, Asuncion, et al.
Publicado: (2013)

Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia
por: Wallihan, Rebecca G., et al.
Publicado: (2018)

Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant
por: Quintero, Ana Maria, et al.
Publicado: (2022)

Definition of erythroid cell‐positive blood transcriptome phenotypes associated with severe respiratory syncytial virus infection
por: Rinchai, Darawan, et al.
Publicado: (2020)

Meeting Report: Harmonization of RSV therapeutics – from design to performance
por: Nair, Harish, et al.
Publicado: (2016)

RSV: perspectives to strengthen the need for protection in all infants
por: Navarro Alonso, Jose Antonio, et al.
Publicado: (2021)

999. Nasal Mucosal Cytokines: Potential Biomarkers for Pediatric Pneumonia Severity and Etiology
por: Sayegh, Rouba, et al.
Publicado: (2021)

2619. Clinical Characteristics and Etiology of Community-Acquired Pneumonia in Children: A Contemporary, Prospective, Multicenter Study in Ohio, 2015–2018
por: Yun, Ki Wook, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19
por: Bline, Katherine, et al.
Publicado: (2022)

2210. Nasopharyngeal Detection of Streptococcus pneumoniae and Clinical Disease Severity in Children with Community-Acquired Pneumonia (CAP)
por: Wook Yun, Ki, et al.
Publicado: (2019)

Prevalence, Genotypes, Clinical Manifestations and Outcomes Associated with Human Parechovirus (HPeV) Infections in Infants up to 2 Months old in Central Ohio
por: Souverbielle, Cristina Tomatis, et al.
Publicado: (2017)

1138 Human Adenovirus (HAdV) Blood Viral Detection is Associated with Higher Viral Load in Immunocompetent Pediatric HAdV Respiratory Samples
por: Song, Eunkyung, et al.
Publicado: (2014)

Enhanced Monocyte Response and Decreased Central Memory T Cells in Children with Invasive Staphylococcus aureus Infections
por: Ardura, Monica I., et al.
Publicado: (2009)

The NA62 LAV front-end electronics
por: Antonelli, A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_innjjsei361piaaipeg2lv1jvv